🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/02/2021 90,00 92,60 87,01 87,48 -2,58% 6,21% 941.500
09/02/2021 88,41 91,10 87,66 89,80 +1,57% 3,89% 552.600
08/02/2021 89,64 90,47 86,12 88,41 -2,28% 4,85% 1.156.400
05/02/2021 82,50 91,70 78,55 90,47 +7,81% 15,94% 1.490.300
04/02/2021 81,61 84,89 79,77 83,92 +4,47% 6,27% 921.000
03/02/2021 79,92 81,89 79,45 80,33 -0,24% 3,05% 568.400
02/02/2021 80,78 82,00 79,95 80,52 +0,95% 2,54% 715.400
01/02/2021 78,03 80,40 77,28 79,76 +3,36% 3,99% 543.600
29/01/2021 78,39 80,89 76,31 77,17 -0,75% 5,84% 986.200
28/01/2021 78,16 79,29 76,50 77,75 +1,21% 3,57% 719.600
27/01/2021 79,55 81,93 75,03 76,82 -5,32% 8,67% 1.005.100
26/01/2021 84,29 85,88 80,86 81,14 -3,55% 5,96% 677.600
25/01/2021 81,85 84,67 80,29 84,13 +2,51% 5,36% 696.500
22/01/2021 79,81 82,24 79,50 82,07 +2,56% 3,43% 822.000
21/01/2021 83,58 84,12 79,49 80,02 -4,10% 5,54% 559.000
20/01/2021 82,59 84,98 82,40 83,44 +1,57% 3,12% 659.100
19/01/2021 80,61 83,45 80,61 82,15 +1,75% 3,53% 538.600
15/01/2021 81,90 84,35 80,52 80,74 -2,56% 4,68% 650.600
14/01/2021 80,95 84,12 80,40 82,86 +2,30% 4,60% 482.600
13/01/2021 82,11 84,55 80,89 81,00 -2,04% 4,46% 709.400
12/01/2021 80,42 82,93 80,01 82,69 +3,22% 3,63% 550.400
11/01/2021 79,00 81,22 78,03 80,11 +0,29% 4,04% 833.200
08/01/2021 78,85 82,25 78,10 79,88 +0,52% 5,26% 937.600
07/01/2021 75,00 79,49 75,00 79,47 +6,84% 5,99% 989.400
06/01/2021 71,62 74,74 70,11 74,38 +2,41% 6,46% 1.720.700
05/01/2021 74,57 74,57 70,45 72,63 -2,94% 5,53% 1.268.600
04/01/2021 76,07 77,11 74,52 74,83 -2,48% 3,40% 1.164.100
31/12/2020 77,81 77,87 75,68 76,73 -0,90% 2,81% 677.700
30/12/2020 78,78 81,28 77,29 77,43 -0,78% 5,06% 693.500
29/12/2020 79,71 79,95 75,25 78,04 -2,38% 5,90% 838.100